Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication

Table 1 Baseline characteristics

Variable	Treatment as usual		Medication review tool
	n/N or mean	% or (SD)	n/N or mean	% or (SD)
Male	20/29	69	23/31	74
Age	39	(11)	45	(10)
White	21/29	72	25/31	81
Single	20/29	69	25/31	81
Unemployed	20/29	69	24/31	77
Number of years been in contact with mental health services
Less than a year	1/29	3	1/31	3
1 to 3 years	3/29	10	4/31	13
4–10 years	5/29	17	2/31	6
More than 10 years	20/29	69	24/31	77
One antipsychotic	22/29	76	27/31	87
Two antipsychotics or more	7/29	24	4/31	13
Total dose per day (Chlorpromazine equivalent (mg)) median (IQR)	400	200, 600	250	132, 400
Taking other medication	24/29	83	23/31	74
Antidepressants	9/29	31	10/31	32
Anxiolytic	2/29	7	3/31	10
Anti cholinergic	10/29	34	7/31	23
Mood stabilisers	9/29	31	5/31	16
Medication for physical illnesses	17/29	59	18/31	58

ISSN: 1471-244X